Table 4 Patient survival by metastasis and splenectomy status
From: Undifferentiated pleomorphic sarcoma of the spleen: a case report and literature review
Patient group | Patients with recorded survival | Survival, n (%) | |||
|---|---|---|---|---|---|
< 1 year | 1–2 years | > 2 years | |||
All patients | Total | 36 | 21 (58.3) | 11 (30.6) | 4 (11.1) |
Splenectomy | 31 | 16 (51.6) | 11 (35.5) | 4 (12.9) | |
No splenectomy | 5 | 5 (100) | 0 | 0 | |
No metastasis present | Total | 24 | 12 (50) | 10 (41.7) | 2 (8.3) |
Splenectomy | 24 | 12 (50) | 10 (41.7) | 2 (8.3) | |
No splenectomy | 0 | 0 | 0 | 0 | |
Metastasis present | Total | 12 | 9 (75) | 1 (8.3) | 2 (16.7) |
Splenectomy | 7 | 4 (57.1) | 1 (14.3) | 2 (28.6) | |
No splenectomy | 5 | 5 (100) | 0 | 0 | |